Faus & Moliner participates in the MBA on Pharma & Biotech and in the Master on Scientific Departments of the Pharmaceutical Industry

Knowledge on protecting inventions, pharmaceutical and biotechnological patents and how to prepare the applications to obtain patents is essential for future professionals in this area.

On 18 November of 2015, Faus & Moliner lawyers Verónica Carías and Carmela Losada taught the seminar “International patent systems” of the 1st Edition of the MBA on Pharma & Biotech of ESAME. Their presentation dealt with subjects such as strategies for the protection of inventions, development on patentable subject matter, types of patents, as well as assessment and requirements of patentability within different procedures.

A week later, on 24 November of 2015, Verónica Carías and Carmela Losada taught the seminar “Industrial property and pharmaceutical products’ patents” included in the programme of the 8th Edition of the Master on Scientific Departments of the Pharmaceutical Industry, co-organized by the University of Barcelona and ESAME. Their presentation dealt with subjects such as industrial property and its different types such as brands, commercial names, utility models, industrial designs, know-how and patents, including also a comparative analysis with other systems that apply “first to invent” vs. “first to file”.

Both seminars included comments about the new Law 24/2015, of 24 July, on Patents, as well as about more specialized subjects within the sector, analyzing the importance of medicine patents, the patentability of pharmaceutical products, swiss-style claims, the Bolar clause and the data exclusivity period, as well as matters such as where and when to patent, how to extend the lifespan of the patent through the complementary protection certificate and the content of a pharmaceutical patent. Finally, after analyzing the risk of patent infringement, they commented the legal actions that the owner of a patent may take if he considers that his right is being infringed and there was a discussion about current cases of interest.

Additionally, more specialized subjects such as the importance of medicine patents and the specialties of their brands or denominations, the patentability of pharmaceutical products, swiss-style claims, the Bolar clause and the data exclusivity period, as well as matters such as where and when to patent, how to extend the lifespan of the patent through the complementary protection certificate and the content of a pharmaceutical patent were analyzed.